XNYS · Healthcare · Medical Distribution
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | Q4 2026 | 11.57 | 11.69 | +1.04% | $96.30B | ✅ Beat | -0.37% | -1.00% | — |
| 2026-02-04 | Q3 2026 | 9.29 | 9.34 | +0.54% | $106.16B | ✅ Beat | +1.82% | +15.96% | +11.83% |
| 2025-11-05 |
| Q2 2026 |
| 9.00 |
| 9.86 |
| +9.56% |
| $103.15B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-06 | Q1 2026 | 8.18 | 8.26 | +0.98% | $97.83B | ✅ Beat | -1.46% | -5.77% | -2.32% |
| 2025-05-08 | Q4 2025 | 9.83 | 10.12 | +2.95% | $90.82B | ✅ Beat | — | — | — |
| 2025-02-05 | Q3 2025 | 7.99 | 8.03 | +0.50% | $95.29B | ✅ Beat | — | — | — |
| 2024-11-06 | Q2 2025 | 6.88 | 7.07 | +2.76% | $93.65B | ✅ Beat | — | — | — |
| 2024-08-07 | Q1 2025 | 7.21 | 7.88 | +9.29% | $79.28B | ✅ Beat | — | — | — |
Showing last 8 quarters.